Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2022

30-05-2022 | Celiac Disease | Editorial

Dating While Gluten-Free—Don’t Kiss and Don’t Tell?

Authors: Javier A. Villafuerte-Gálvez, Jocelyn A. Silvester

Published in: Digestive Diseases and Sciences | Issue 11/2022

Login to get access

Excerpt

Celiac disease (CeD) is the sole autoimmune disease with an identified antigen (gluten). A lifelong breakup with gluten—a.k.a. “gluten-free diet” (GFD)—is currently the only known effective treatment, and breaking up is hard to do. Gluten’s ubiquity necessitates sustained daily investment of cognitive, physical, monetary, and emotional resources from patients with CeD. When dining out, this often entails explaining a gluten-free diet to wait staff while enquiring about the details of food preparation. The perceived treatment burden of CeD has been estimated to be comparable to that of diabetes, congestive heart failure, or renal failure requiring dialysis [1]. …
Literature
1.
go back to reference Shah S, Akbari M, Vanga R, Kelly CP, Hansen J, Theethira T et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109:1304–1311.CrossRef Shah S, Akbari M, Vanga R, Kelly CP, Hansen J, Theethira T et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109:1304–1311.CrossRef
2.
go back to reference Meyer S, Lamash L. Illness identity in adolescents with celiac disease. J Pediatr Gastroenterol Nutr. 2021;72:e42–e47.CrossRef Meyer S, Lamash L. Illness identity in adolescents with celiac disease. J Pediatr Gastroenterol Nutr. 2021;72:e42–e47.CrossRef
3.
go back to reference Silvester JA, Graff LA, Rigaux L, Walker JR, Duerksen DR. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther. 2016;44:612–619.CrossRef Silvester JA, Graff LA, Rigaux L, Walker JR, Duerksen DR. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther. 2016;44:612–619.CrossRef
6.
go back to reference Maloney JM, Chapman MD, Sicherer SH. Peanut allergen exposure through saliva: assessment and interventions to reduce exposure. J Allergy Clin Immunol. 2006;118:719–724.CrossRef Maloney JM, Chapman MD, Sicherer SH. Peanut allergen exposure through saliva: assessment and interventions to reduce exposure. J Allergy Clin Immunol. 2006;118:719–724.CrossRef
7.
go back to reference Ludvigsson JF, Lebwohl B, Chen Q, Bröms G, Wolf RL, Green PHR et al. Anxiety after coeliac disease diagnosis predicts mucosal healing: a population-based study. Aliment Pharmacol Ther. 2018;48:1091–1098.CrossRef Ludvigsson JF, Lebwohl B, Chen Q, Bröms G, Wolf RL, Green PHR et al. Anxiety after coeliac disease diagnosis predicts mucosal healing: a population-based study. Aliment Pharmacol Ther. 2018;48:1091–1098.CrossRef
8.
go back to reference Wolf RL, Lebwohl B, Lee AR, Zybert P, Reilly NR, Cadenhead J et al. Hypervigilance to a gluten-free diet and decreased quality of life in teenagers and adults with celiac disease. Dig Dis Sci. 2018;63:1438–1448.CrossRef Wolf RL, Lebwohl B, Lee AR, Zybert P, Reilly NR, Cadenhead J et al. Hypervigilance to a gluten-free diet and decreased quality of life in teenagers and adults with celiac disease. Dig Dis Sci. 2018;63:1438–1448.CrossRef
Metadata
Title
Dating While Gluten-Free—Don’t Kiss and Don’t Tell?
Authors
Javier A. Villafuerte-Gálvez
Jocelyn A. Silvester
Publication date
30-05-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07553-1

Other articles of this Issue 11/2022

Digestive Diseases and Sciences 11/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.